Rickets (or osteomalacia) is well known to occur in patients taking long-term anticonvulsant therapy (Kruse, 1968; Dent et al., 1970; De Luca, Masotti, and Partington, 1972; Silver et al., 1974; Hahn et al., 1975; Borgstedt, et al., 1972) but the occurrence of this complication in tuberous sclerosis has been commented on only once (Borgstedt et al., 1972) . This paper reports this occurrence in 5 children seen in the general paediatric unit of this hospital in the past 5 years.
Case reports Case 1. A 15-year-old girl with severe mental retardation, a long history of seizures, marked adenoma sebaceum, and many cutaneous white macules was referred from the orthopaedic clinic, where she had attended with fractures of the left radius and scapula, right lateral malleolus, and both clavicles. Gross rickets and secondary hyperparathyroidism was shown radiographically (Fig. 1 ) and chemical analysis of plasma showed calcium 2 * 18 mmol/l (8 * 7 mg/100 ml), phosphate 1*02 mmol/l (3-1 mg/100 ml), alkaline phosphatase 1220 IU/I. Plasma urea was 2-2 mmol/l (13 mg/100 ml) and there was a generalized aminoaciduria but no reducing substances in the urine. There was no clinical suggestion of intestinal malabsorption.
She had had infantile spasms with hypsarrhythmia between the ages of 5 and 10 months but was not treated at that time. The diagnosis of tuberous sclerosis had been made at the age of 4 years when she presented with generalized seizures and mental retardation, from which time she had taken primidone, ethosuximide and sulthiame subsequently having been added. Her diet had been normal, though she had never liked milk, and she had not been deprived of exposure to sunlight.
Treatment was begun with calciferol 10 000 units daily, increasing after 3 months to 15 000 units daily, and supplemental calcium (Calcium Sandoz 30-45 ml daily). There was gradual radiographic and biochemical (Fig. 2) improvement, though the plasma calcium was still low after 6 months of treatment.
Case 2. A 13-year-old boy with mental retardation, temporal lobe epilepsy, adenoma sebaceum, cutaneous neurofibromata, a shagreen patch, and intracranial calcification presented with infantile spasms at the age of 3 months, when he was treated with ACTH and phenobarbitone. He took phenobarbitone continuously to the age 12 years, when primidone was substituted because of his aggressive behaviour, for which he was also given diazepam and later thioridazine. There was no clinical evidence of rickets, but investigation showed plasma calcium 2 -55 mmol/l (10 mg/100 ml), phosphate 1-82 mmol/l (5-6 mg/100 ml), and alkaline phosphatase 640 IU/l; plasma 5-nucleotidase 5 * 5 IU/l. X-rays of pelvis, scapulae, wrists, and knees were normal. Treatment was started with calciferol 1000 units daily, and plasma alkaline phosphatase fell gradually to 317 IU/l over the next 3 months. The place of vitamin D prophylaxis for patients taking anticonvulsant therapy has been debated, but it seems reasonable to suggest that such prophylaxis may be particularly indicated in tuberous sclerosis. The amount of vitamin D required is uncertain, but is probably of the order of 500-1000 units as a daily supplement to a normal diet (Hahn et al., 1975; Silver et al., 1974 
